恒瑞医药：收到关于富马酸泰吉利定注射液的《药物临床试验批准通知书》

Core Viewpoint - Heng Rui Medicine has received approval from the National Medical Products Administration for the clinical trial of fumaric acid tegafur injection, indicating progress in its drug development pipeline [1] Group 1 - The company announced the receipt of the clinical trial approval notice on November 17 [1] - The approval is a significant step for the company's research and development efforts in the pharmaceutical sector [1]